Answer Summary

Members shared their experiences with diffuse large B-cell lymphoma (DLBCL), with many reporting successful remission after R-CHOP... Read more

Members shared their experiences with diffuse large B-cell lymphoma (DLBCL), with many reporting successful remission after R-CHOP chemotherapy, though treatment timelines and outcomes varied widely from complete remission within months to recurrences requiring advanced therapies like CAR-T cell treatment. Several members described persistent side effects including neuropathy, fatigue, cognitive difficulties, muscle weakness, and compromised immune systems, with many emphasizing the importance of staying active, monitoring bloodwork closely, and maintaining a positive outlook throughout recovery. A recurring theme was the challenge of finding others with lymphoma in the same location, particularly for rare presentations like brain involvement, alongside deep gratitude for successful treatment, supportive medical teams, and the strength found through faith and community connection.